Kashuba AD - Search Results

1

Ritonavir, saquinavir, and efavirenz, but not nevirapine, inhibit bile acid transport in human and rat hepatocytes.

McRae MP, Lowe CM, Tian X, Bourdet DL, Ho RH, Leake BF, Kim RB, Brouwer KL, Kashuba AD. McRae MP, et al. Among authors: kashuba ad. J Pharmacol Exp Ther. 2006 Sep;318(3):1068-75. doi: 10.1124/jpet.106.102657. Epub 2006 May 23. J Pharmacol Exp Ther. 2006. PMID: 16720753

2

Simple and rapid quantification of the non-nucleoside reverse transcriptase inhibitors nevirapine, delavirdine, and efavirenz in human blood plasma using high-performance liquid chromatography with ultraviolet absorbance detection.

Rezk NL, Tidwell RR, Kashuba AD. Rezk NL, et al. Among authors: kashuba ad. J Chromatogr B Analyt Technol Biomed Life Sci. 2002 Jul 5;774(1):79-88. doi: 10.1016/s1570-0232(02)00210-6. J Chromatogr B Analyt Technol Biomed Life Sci. 2002. PMID: 12052725

3

Pharmacokinetic and pharmacodynamic investigation of efavirenz in the semen and blood of human immunodeficiency virus type 1-infected men.

Reddy YS, Gotzkowsky SK, Eron JJ, Kim JY, Fiske WD, Fiscus SA, Petch L, Cohen MS, Kashuba AD. Reddy YS, et al. Among authors: kashuba ad. J Infect Dis. 2002 Nov 1;186(9):1339-43. doi: 10.1086/344311. Epub 2002 Oct 7. J Infect Dis. 2002. PMID: 12402205 Clinical Trial.

4

Cytokine regulation of P-glycoprotein.

McRae MP, Brouwer KL, Kashuba AD. McRae MP, et al. Among authors: kashuba ad. Drug Metab Rev. 2003 Feb;35(1):19-33. doi: 10.1081/dmr-120018247. Drug Metab Rev. 2003. PMID: 12635814 Review.

5

Drug-drug interactions and the pharmacotherapy of HIV infection.

Kashuba AD. Kashuba AD. Top HIV Med. 2005 Jun-Jul;13(2):64-9. Top HIV Med. 2005. PMID: 16082056 Review.

6

Lopinavir/ritonavir reduces bupropion plasma concentrations in healthy subjects.

Hogeland GW, Swindells S, McNabb JC, Kashuba AD, Yee GC, Lindley CM. Hogeland GW, et al. Among authors: kashuba ad. Clin Pharmacol Ther. 2007 Jan;81(1):69-75. doi: 10.1038/sj.clpt.6100027. Clin Pharmacol Ther. 2007. PMID: 17186001 Clinical Trial.

7

High-performance liquid chromatography assay for the determination of the HIV-protease inhibitor tipranavir in human plasma in combination with nine other antiretroviral medications.

Choi SO, Rezk NL, Kashuba AD. Choi SO, et al. Among authors: kashuba ad. J Pharm Biomed Anal. 2007 Mar 12;43(4):1562-7. doi: 10.1016/j.jpba.2006.11.017. Epub 2007 Jan 22. J Pharm Biomed Anal. 2007. PMID: 17236737

8

Mechanisms of pharmacokinetic and pharmacodynamic drug interactions associated with ritonavir-enhanced tipranavir.

Vourvahis M, Kashuba AD. Vourvahis M, et al. Among authors: kashuba ad. Pharmacotherapy. 2007 Jun;27(6):888-909. doi: 10.1592/phco.27.6.888. Pharmacotherapy. 2007. PMID: 17542771 Review.

9

Plasma bile acid concentrations in patients with human immunodeficiency virus infection receiving protease inhibitor therapy: possible implications for hepatotoxicity.

McRae M, Rezk NL, Bridges AS, Corbett AH, Tien HC, Brouwer KL, Kashuba AD. McRae M, et al. Among authors: kashuba ad. Pharmacotherapy. 2010 Jan;30(1):17-24. doi: 10.1592/phco.30.1.17. Pharmacotherapy. 2010. PMID: 20030469 Free PMC article.

10

A phenotype-genotype approach to predicting CYP450 and P-glycoprotein drug interactions with the mixed inhibitor/inducer tipranavir/ritonavir.

Dumond JB, Vourvahis M, Rezk NL, Patterson KB, Tien HC, White N, Jennings SH, Choi SO, Li J, Wagner MJ, La-Beck NM, Drulak M, Sabo JP, Castles MA, Macgregor TR, Kashuba AD. Dumond JB, et al. Among authors: kashuba ad. Clin Pharmacol Ther. 2010 Jun;87(6):735-42. doi: 10.1038/clpt.2009.253. Epub 2010 Feb 10. Clin Pharmacol Ther. 2010. PMID: 20147896 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

277 results

Search Page

Filters